Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 4:01 PM ET

Date/Time Source News Release
12/17/2021 01:00 AM EST Business Wire Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership
12/23/2020 02:00 PM EST Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Genfit S.A. (GNFT) on Behalf of Investors
03/27/2019 06:13 PM EDT GlobeNewswire Nasdaq Welcomes GENFIT S.A. (Nasdaq: GNFT) to The Nasdaq Stock Market
Page
  • 1

Additional News

As of April 30, 2025 • 4:01 PM ET

Date/Time Source News Release
04/03/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, April 3rd, 2025
04/03/2025 05:30 AM EDT US Earnings Reports Expected earnings - GENFIT S.A.
04/02/2025 06:44 PM EDT KlickAnalytics GNFT - Historical Earnings Price Analysis
02/21/2025 03:53 AM EST SeekingAlpha Genfit reports preliminary results of repurchase offer to 2025 OCEANEs holders
11/21/2024 12:50 AM EST SeekingAlpha Genfit Balances Ipsen Partnership With High-Risk Pipeline Ambitions
11/08/2024 10:26 PM EST Stock Traders Daily Long Term Trading Analysis for (GNFT)
11/07/2024 06:09 PM EST SeekingAlpha Genfit reports 9M results
10/01/2024 05:40 AM EDT US Earnings Reports Expected earnings - GENFIT S.A.
09/19/2024 04:27 PM EDT SeekingAlpha Genfit GAAP EPS of Euro0.53, revenue of Euro61.2M
08/14/2024 02:25 PM EDT SeekingAlpha Gilead wins FDA nod for liver disease drug
Page